{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:10:43Z","timestamp":1770322243383,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["WB-2021-35949"],"award-info":[{"award-number":["WB-2021-35949"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["RS19\/75-59"],"award-info":[{"award-number":["RS19\/75-59"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["RS20\/75-66"],"award-info":[{"award-number":["RS20\/75-66"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["TADH27012"],"award-info":[{"award-number":["TADH27012"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["RS25\/75-76"],"award-info":[{"award-number":["RS25\/75-76"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007394","name":"Association Laurette Fugain","doi-asserted-by":"publisher","award":["2024\/11"],"award-info":[{"award-number":["2024\/11"]}],"id":[{"id":"10.13039\/100007394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-19-CE14-0014"],"award-info":[{"award-number":["ANR-19-CE14-0014"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["PDF20191209849"],"award-info":[{"award-number":["PDF20191209849"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41375-025-02846-6","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:47:24Z","timestamp":1767782844000},"page":"449-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction"],"prefix":"10.1038","volume":"40","author":[{"given":"Marianne","family":"Ayoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casilda","family":"Hitier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Dehgane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-6614","authenticated-orcid":false,"given":"Mariana","family":"Tannoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8080-839X","authenticated-orcid":false,"given":"Ivan","family":"Nemazanyy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-755X","authenticated-orcid":false,"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8864-4801","authenticated-orcid":false,"given":"Karim","family":"Maloum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Ringshausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3427-7596","authenticated-orcid":false,"given":"Elise","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5744-5612","authenticated-orcid":false,"given":"Delphine","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3954-9207","authenticated-orcid":false,"given":"Marie","family":"Lagouge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-5231","authenticated-orcid":false,"given":"Leticia K.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-1628","authenticated-orcid":false,"given":"Santos A.","family":"Susin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"2846_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.critrevonc.2016.06.003","volume":"104","author":"L Scarf\u00f2","year":"2016","unstructured":"Scarf\u00f2 L, Ferreri AJ, Ghia P. Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016;104:169\u201382.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2846_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","volume":"369","author":"JC Byrd","year":"2013","unstructured":"Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369:32\u201342.","journal-title":"N Engl J Med"},{"key":"2846_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11864-021-00862-z","volume":"22","author":"GF Perini","year":"2021","unstructured":"Perini GF, Feres CCP, Teixeira LLC, Hamerschlak N. BCL-2 inhibition as treatment for chronic lymphocytic leukemia. Curr Treat Options Oncol. 2021;22:66.","journal-title":"Curr Treat Options Oncol"},{"key":"2846_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47305-2","volume":"9","author":"B Sharif-Askari","year":"2019","unstructured":"Sharif-Askari B, Doyon D, Paliouras M, Aloyz R. Bruton\u2019s tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes. Sci Rep. 2019;9:11069.","journal-title":"Sci Rep"},{"key":"2846_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","volume":"36","author":"R Gui\u00e8ze","year":"2019","unstructured":"Gui\u00e8ze R, Liu VM, Rosebrock D, Jourdain AA, Hern\u00e1ndez-S\u00e1nchez M, Martinez Zurita A, et al. Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies. Cancer Cell. 2019;36:369\u201384.e13.","journal-title":"Cancer Cell"},{"key":"2846_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1005659","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu J, Chen Y, Yu L, Yang L. Mechanisms of venetoclax resistance and solutions. Front Oncol. 2022;12:1005659.","journal-title":"Front Oncol"},{"key":"2846_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood.2021013990","volume":"140","author":"Z Chen","year":"2022","unstructured":"Chen Z, Simon-Molas H, Cretenet G, Valle-Argos B, Smith LD, Forconi F, et al. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood. 2022;140:630\u201343.","journal-title":"Blood"},{"key":"2846_CR8","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1182\/blood-2013-10-532200","volume":"123","author":"R Jitschin","year":"2014","unstructured":"Jitschin R, Hofmann AD, Bruns H, Giessl A, Bricks J, Berger J, et al. Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia. Blood. 2014;123:2663\u201372.","journal-title":"Blood"},{"key":"2846_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41375-023-02103-8","volume":"38","author":"M Tannoury","year":"2024","unstructured":"Tannoury M, Ayoub M, Dehgane L, Nemazanyy I, Dubois K, Izabelle C, et al. ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia. Leukemia. 2024;38:302\u201317.","journal-title":"Leukemia"},{"key":"2846_CR10","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.3390\/ijms222111938","volume":"22","author":"LX Zampieri","year":"2021","unstructured":"Zampieri LX, Sboarina M, Cacace A, Grasso D, Thabault L, Hamelin L, et al. Olaparib is a mitochondrial complex I inhibitor that kills temozolomide-resistant human glioblastoma cells. Int J Mol Sci. 2021;22:11938.","journal-title":"Int J Mol Sci"},{"key":"2846_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41375-020-0714-3","volume":"34","author":"M Quijada-\u00c1lamo","year":"2020","unstructured":"Quijada-\u00c1lamo M, Hern\u00e1ndez-S\u00e1nchez M, Alonso-P\u00e9rez V, Rodr\u00edguez-Vicente AE, Garc\u00eda-Tu\u00f1\u00f3n I, Mart\u00edn-Izquierdo M, et al. CRISPR\/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition. Leukemia. 2020;34:1599\u2013612.","journal-title":"Leukemia"},{"key":"2846_CR12","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1182\/blood-2010-01-265769","volume":"116","author":"VJ Weston","year":"2010","unstructured":"Weston VJ, Oldreive CE, Skowronska A, Oscier DG, Pratt G, Dyer MJ, et al. The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood. 2010;116:4578\u201387.","journal-title":"Blood"},{"key":"2846_CR13","doi-asserted-by":"publisher","first-page":"e76607","DOI":"10.1371\/journal.pone.0076607","volume":"8","author":"E Hertlein","year":"2013","unstructured":"Hertlein E, Beckwith KA, Lozanski G, Chen TL, Towns WH, Johnson AJ, et al. Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease. PLoS ONE. 2013;8:e76607.","journal-title":"PLoS ONE"},{"key":"2846_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40617-3","volume":"9","author":"EY Kim","year":"2019","unstructured":"Kim EY, Chung TW, Han CW, Park SY, Park KH, Jang SB, et al. A novel lactate dehydrogenase inhibitor, 1-(phenylseleno)-4-(trifluoromethyl) benzene, suppresses tumor growth through apoptotic cell death. Sci Rep. 2019;9:3969.","journal-title":"Sci Rep"},{"key":"2846_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33739-2","volume":"13","author":"M Mangolini","year":"2022","unstructured":"Mangolini M, Maiques-Diaz A, Charalampopoulou S, Gerhard-Hartmann E, Bloehdorn J, Moore A, et al. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape. Nat Commun. 2022;13:6220.","journal-title":"Nat Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02846-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02846-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02846-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:56:01Z","timestamp":1770274561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02846-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2846"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02846-6","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patient samples were collected after the provision of informed consent and in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}